Exelixis (EXEL) Operating Margin Growth (1y) (2011 - 2026)
Exelixis (EXEL) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | 1,049.00 |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 1,997.00 |
| 10 | Exelixis | 14.50 Bn | 13.72 Bn | 590.86 Mn | 751.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 751.00 |
| Jan 2, 2026 | 1,049.00 |
| Oct 3, 2025 | 1,435.00 |
| Jul 4, 2025 | -571.00 |
| Apr 4, 2025 | 2,671.00 |
| Jan 3, 2025 | 1,175.00 |
| Sep 27, 2024 | 2,895.00 |
| Jun 28, 2024 | 2,673.00 |
| Mar 29, 2024 | -12.00 |
| Dec 29, 2023 | 2,839.00 |
| Sep 29, 2023 | -2,379.00 |
| Jun 30, 2023 | -339.00 |
| Mar 31, 2023 | -1,633.00 |
| Sep 30, 2022 | 435.00 |
| Jul 1, 2022 | -1,198.00 |
| Apr 1, 2022 | 2,509.00 |
| Oct 1, 2021 | 3,414.00 |
| Jul 2, 2021 | 283.00 |
| Apr 2, 2021 | -2,498.00 |
| Jan 1, 2021 | -2,318.00 |